364 related articles for article (PubMed ID: 27452482)
1. Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP(+) exposure.
Dukes AA; Bai Q; Van Laar VS; Zhou Y; Ilin V; David CN; Agim ZS; Bonkowsky JL; Cannon JR; Watkins SC; Croix CM; Burton EA; Berman SB
Neurobiol Dis; 2016 Nov; 95():238-49. PubMed ID: 27452482
[TBL] [Abstract][Full Text] [Related]
2. Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells.
Lu XL; Lin YH; Wu Q; Su FJ; Ye CH; Shi L; He BX; Huang FW; Pei Z; Yao XL
BMC Complement Altern Med; 2015 Apr; 15():137. PubMed ID: 25925762
[TBL] [Abstract][Full Text] [Related]
3. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ -induced neurodegeneration.
Cartelli D; Ronchi C; Maggioni MG; Rodighiero S; Giavini E; Cappelletti G
J Neurochem; 2010 Oct; 115(1):247-58. PubMed ID: 20649848
[TBL] [Abstract][Full Text] [Related]
4. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP.
Filichia E; Hoffer B; Qi X; Luo Y
Sci Rep; 2016 Sep; 6():32656. PubMed ID: 27619562
[TBL] [Abstract][Full Text] [Related]
6. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
Martí Y; Matthaeus F; Lau T; Schloss P
Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
[TBL] [Abstract][Full Text] [Related]
7. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
Kawahata I; Bousset L; Melki R; Fukunaga K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C.
Morfini G; Pigino G; Opalach K; Serulle Y; Moreira JE; Sugimori M; Llinás RR; Brady ST
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2442-7. PubMed ID: 17287338
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP.
Mapa MST; Le VQ; Wimalasena K
PLoS One; 2018; 13(8):e0197946. PubMed ID: 30138351
[TBL] [Abstract][Full Text] [Related]
11. The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons.
Kim-Han JS; Antenor-Dorsey JA; O'Malley KL
J Neurosci; 2011 May; 31(19):7212-21. PubMed ID: 21562285
[TBL] [Abstract][Full Text] [Related]
12. Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.
Van Laar VS; Berman SB; Hastings TG
Neurobiol Dis; 2016 Jul; 91():247-61. PubMed ID: 27001148
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
Lee Y; Heo G; Lee KM; Kim AH; Chung KW; Im E; Chung HY; Lee J
Brain Res; 2017 May; 1663():184-193. PubMed ID: 28322751
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan Suppresses Mitochondrial Dysfunction and Cell Death against 1-Methyl-4-Phenylpyridinum-Induced Neuronal Cytotoxicity via Regulation of PGC-1α Expression.
Han YS; Lee JH; Lee SH
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480724
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.
Van Laar VS; Arnold B; Howlett EH; Calderon MJ; St Croix CM; Greenamyre JT; Sanders LH; Berman SB
J Neurosci; 2018 Aug; 38(34):7505-7515. PubMed ID: 30030401
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo.
Van Laar VS; Chen J; Zharikov AD; Bai Q; Di Maio R; Dukes AA; Hastings TG; Watkins SC; Greenamyre JT; St Croix CM; Burton EA
Redox Biol; 2020 Oct; 37():101695. PubMed ID: 32905883
[TBL] [Abstract][Full Text] [Related]
17. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
Nakai M; Mori A; Watanabe A; Mitsumoto Y
Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872
[TBL] [Abstract][Full Text] [Related]
18. Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.
Li DW; Yao M; Dong YH; Tang MN; Chen W; Li GR; Sun BQ
Int J Mol Med; 2014 Nov; 34(5):1358-64. PubMed ID: 25174304
[TBL] [Abstract][Full Text] [Related]
19. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
20. Transgenic Zebrafish Expressing mCherry in the Mitochondria of Dopaminergic Neurons.
Noble S; Godoy R; Affaticati P; Ekker M
Zebrafish; 2015 Oct; 12(5):349-56. PubMed ID: 26355474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
